The association between SGLT2 inhibitors and new-onset acute coronary syndrome in the elderly: a population-based longitudinal cohort study

BACKGROUND: Several observational cohorts and meta-analytical studies on humans have shown that users of sodium-glucose cotransporter-2 inhibitors (SGLT2is) have a lower risk for new-onset acute coronary syndrome (ACS) than nonusers. However, some studies, including randomized clinical trials, repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tsung-Kun, Lee, Mei-Chun, Cheng, Yu-Han, Ma, Timothy, Chen, Mei-Chun, Yang, Tsung-Yuan, Jong, Gwo-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433571/
https://www.ncbi.nlm.nih.gov/pubmed/37592322
http://dx.doi.org/10.1186/s13098-023-01143-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433571/
https://www.ncbi.nlm.nih.gov/pubmed/37592322
http://dx.doi.org/10.1186/s13098-023-01143-5

Ejemplares similares